11 employees
Pykus Therapeutics are develop a dissolvable intraocular surgical device to make retinal surgery less painful and more successful.
2016
$2.5M
from 2 investors over 2 rounds
Pykus Therapeutics raised $2.5M on February 4, 2021
Investors: Partners HealthCare
Pykus Therapeutics raised undisclosed on January 1, 2018
Investors: Beacon Angels